Drug & medication recalls

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Fexofenadine Hydrochloride Tablets, USP 60 mg, Allergy, Non-Drowsy, Antihistamine, 100 tablets (10 X 10) per UD Cartons…

Recall date
March 26, 2015
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-1083-2015
FDA classification
Class III
Brand / firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Sold / distributed
Nationwide

Why it was recalled

Failed Impurities/Degradation Specifications: the manufacturer, recalled product due to slightly above specification results for a Related Compound during routine stability testing

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Fexofenadine Hydrochloride Tablets, USP 60 mg, Allergy, Non-Drowsy, Antihistamine, 100 tablets (10 X 10) per UD Cartons, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, USA, NDC 51079-547-20

Get recall alerts

Free email alert whenever Mylan Institutional, Inc. (d.b.a. UDL Laboratories) has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Mylan Institutional, Inc. (d.b.a. UDL Laboratories)